QQ客服 官方微博 反馈留言

	Promoter hypermethylation of RAR beta 2, DAPK, hMLH1, p14, and p15 is associated with progression of breast cancer A PRISMA-compliant meta-analysis
	Qi, Ming; Xiong, Xiang
刊名	MEDICINE
	2018
卷号	97期号:51
关键词	breast cancer DARK hMLH1 meta-analysis p14 p15 promoter hypermethylation RAR beta 2
DOI	10.1097/MD.0000000000013666
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4580106
专题	山东大学
作者单位	1.Shandong Univ, Shandong Prov Hosp, Dept Breast & Thyroid Surg, Changsha, Hunan, Peoples R China. 2.Cent S Univ, Xiangya Hos
推荐引用方式 GB/T 7714	Qi, Ming,Xiong, Xiang. Promoter hypermethylation of RAR beta 2, DAPK, hMLH1, p14, and p15 is associated with progression of breast cancer A PRISMA-compliant meta-analysis[J]. MEDICINE,2018,97(51).
APA	Qi, Ming,&Xiong, Xiang.(2018).Promoter hypermethylation of RAR beta 2, DAPK, hMLH1, p14, and p15 is associated with progression of breast cancer A PRISMA-compliant meta-analysis.MEDICINE,97(51).
MLA	Qi, Ming,et al."Promoter hypermethylation of RAR beta 2, DAPK, hMLH1, p14, and p15 is associated with progression of breast cancer A PRISMA-compliant meta-analysis".MEDICINE 97.51(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。